Prescription opioid misuse among chronic pain patients is undergirded by self-regulatory deficits, affective distress, and opioid-cue reactivity. Dispositional mindfulness has been associated with enhanced selfregulation, lower distress, and adaptive autonomic responses following drug-cue exposure. We hypothesized that dispositional mindfulness might serve as a protective factor among opioid-treated chronic pain patients. We examined heart-rate variability (HRV) during exposure to opioid cues and depressed mood as mediators of the association between dispositional mindfulness and opioid craving. Data were obtained from a sample of chronic pain patients (N ϭ 115) receiving long-term opioid pharmacotherapy. Participants self-reported opioid craving and depression, and HRV was measured during an opioid-cue dot-probe task. Dispositional mindfulness was significantly positively correlated with HRV, and HRV was significantly inversely associated with opioid craving. Dispositional mindfulness was significantly negatively correlated with depression, and depression was significantly positively correlated with opioid craving. Path analysis revealed significant indirect effects of dispositional mindfulness on craving through both HRV and depression. Dispositional mindfulness may buffer against opioid craving among chronic pain patients prescribed opioids; this buffering effect may be a function of improved autonomic and affective responses.
baseline depression (Garland, Bell, Atchley, & Froeliger, in press; Krupitsky et al., 2016) . Opioid-treated chronic pain patients may be especially vulnerable to addiction (Volkow & McLellan, 2016) and subsequent reward dysregulation by way of two conditioned responses, wherein pain relief and opioid-induced euphoria become associated with opioid cues via negative and positive reinforcement, respectively (Fields, 2004; Shippenberg, Bals-Kubik, & Herz, 1993) . This conditioning process may result in opioid-cue reactivity manifested in cue-elicited attentional and autonomic responses (Back et al., 2014; Garland, Froeliger, & Howard, 2014 . It appears that when opioid-cue reactivity is coupled with depressed mood-stemming from the emotion dysregulatory effects of addiction (Shurman, Koob, & Gutstein, 2010) -opioidtreated patients may experience an upwelling of craving (Martel, Dolman, Edwards, Jamison, & Wasan, 2014; Wasan et al., 2012) and consequently engage in opioid-misusing behaviors like unauthorized dose escalation. Hence, craving may arise as a result of dysregulated attentional and emotional processes that, in turn, ultimately lead to behavioral disinhibition and loss of control over substance use (Volkow, Fowler, Wang, & Goldstein, 2002) . Intact self-regulatory capacity therefore appears to be crucial in the successful management of opioid craving and prevention of opioid misuse.
Individuals who are predisposed to misuse prescription opioids may have low self-regulatory capacity and thereby suffer from dysregulated negative emotions (Garland, Bryan, Nakamura, Froeliger, & Howard, 2017; Garland et al., in press ). Indeed, approximately 25% of opioid-treated chronic pain patients self-report aberrant drug-related behaviors such as misuse of opioids to selfmedicate depressed mood and other negative affective states (Vowles et al., 2015) . Compounding this potential preexisting vulnerability, recurrent opioid misuse may impair brain circuits involved in self-regulation and reward processing through an allostatic process (Koob & Le Moal, 2001) , resulting in the downward spiral of behavioral escalation linking chronic pain to opioid misuse (Garland, Froeliger, Passik, & Howard, 2013) . In light of these clinically relevant considerations, research is needed to examine protective factors that may buffer against dysregulation of the integrated network of autonomic, attentional, and affective processes that mediate medication adherence and opioid misuse.
Dispositional mindfulness may be one such protective factor. Defined as the trait-like propensity to exhibit mindful qualities in everyday life, dispositional mindfulness encompasses various facets of self-regulation, including acceptance, nonreactivity to distressing thoughts and emotions, and awareness of interoceptive and exteroceptive sensations and perceptions (Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006; Brown, Ryan, & Creswell, 2007) . Though it is a naturally occurring trait, dispositional mindfulness can be enhanced through mindfulness training, such as that provided by mindfulness-based interventions (Carmody & Baer, 2008; Kiken, Garland, Bluth, Palsson, & Gaylord, 2015) . Mindfulness has been associated with improved ability to regulate attention (Tang, Hölzel, & Posner, 2015) and emotions (Garland, Farb, Goldin, & Fredrickson, 2015; Keng, Smoski, & Robins, 2011; Teper, Segal, & Inzlicht, 2013) , as well as with increased autonomic flexibility (Garland, Froeliger, 2014; Garland, Gaylord, Boettiger, & Howard, 2010; Mankus, Aldao, Kerns, Mayville, & Mennin, 2013) . Dispositional mindfulness has also been inversely correlated with depressed mood (Pearson, Brown, Bravo, & Witkiewitz, 2015; Paul, Stanton, Greeson, Smoski, & Wang, 2013) , and drug craving (Garland, Roberts-Lewis, Kelly, Tronnier, & Hanley, 2014) . Specific to opioid misuse, low dispositional mindfulness is associated with greater use of opioids to self-medicate depressed mood and other negative emotions (Garland, Hanley, Thomas, Knoll, & Ferraro, 2015) . Moreover, opioid-treated chronic pain patients who participated in a mindfulness-based intervention demonstrated significantly greater increases in autonomic control and decreases in opioid craving during attention to opioid cues following treatment (Garland, Froeliger, 2014) . Taken together, these findings suggest that mindfulness may reflect the capacity to self-regulate attentional and emotional responses elicited by opioid cues.
Self-regulation has thus emerged as an important variable in both addiction and mindfulness research. According to the neurovisceral integration theory (Thayer & Lane, 2000 , selfregulation during attention to appetitive stimuli can be indexed by phasic heart-rate variability (HRV): the beat-to-beat, highfrequency variation in heart rate governed by the autonomic nervous system and controlled by the cortico-limbic-striatal network, which modulates attention and emotion (Thayer, Ahs, Fredrikson, Sollers, & Wager, 2012) . Recent meta-analytic research demonstrates a statistically significant, albeit small, relation between HRV and various measures of self-regulation (Holzman & Bridgett, 2017) . Whereas higher resting HRV is generally understood as an indicator of adaptive function, interpretation of phasic HRV is more nuanced. As Laborde, Mosley, and Thayer (2017) recently observed, higher phasic HRV may be interpreted as maladaptive in the absence of executive functioning requirements, but adaptive during tasks that require executive functioning, such as attentional engagement and disengagement in response to emotionally salient information. Consistent with these interpretive parameters, research examining phasic HRV as a marker of selfregulatory capacity among opioid-misusing chronic pain patients shows that, relative to nonmisusers, opioid misusers have significantly lower phasic HRV during attention to opioid-related cues (Garland, Froeliger, 2015) . On the other end of the spectrum, phasic HRV also appears as a marker of self-regulation in mindfulness research. Dispositional mindfulness has been linked with faster recovery from acute stress, inferred from higher phasic HRV (Corey et al., 2012) . Moreover, dispositional mindfulness has been associated with higher phasic HRV during exposure to alcohol cues (Garland, 2011 )-a finding that parallels results from a Randomized controlled trial (RCT) demonstrating mindfulness training increases phasic HRV in response to alcohol cues (Garland et al., 2010) . Associations between dispositional mindfulness and phasic HRV during attention to opioid cues have not yet been explored.
To test whether dispositional mindfulness might serve as a protective factor to buffer against autonomic opioid-cue reactivity, craving, and attendant depressed mood symptoms, we conducted a secondary analysis of baseline data obtained from a clinical trial of opioid-treated chronic pain patients (Garland, Manusov, et al., 2014) . We formed a two-pronged hypothesis. First, we predicted that dispositional mindfulness would be negatively associated with opioid craving, and depressed mood, and positively associated with phasic HRV during attention to opioid-related cues. Second, we posited that depression and phasic HRV would mediate the relationship between dispositional mindfulness and opioid craving. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Method Participants
Individuals diagnosed with chronic pain conditions were recruited from primary-care, pain, and neurology clinics in the southeast United States between 2011 and 2012. Participants met inclusion criteria if they reported chronic, noncancer-related pain and had taken opioid analgesics at least 5 days of each week for no less than the past 90 days (Chou et al., 2009) . Exclusion criteria were active suicidality or psychosis, assessed with the MiniInternational Neuropsychiatric Interview (M. I. N. I.; Sheehan et al., 1998) .
Procedure
Prior to participant recruitment, the study was reviewed and approved by the institutional review board at Florida State University (where the second author was located during data collection). Individuals who met study inclusion criteria and consented to participate completed a battery of self-report measures that captured demographic and clinical information, followed by a psychophysiological assessment conducted by trained research assistants. All participants were compensated $25 for completing the study.
Measures
Dispositional mindfulness. Dispositional mindfulness was measured with the Five Facet Mindfulness Questionnaire (FFMQ; Baer et al., 2006 ), a 39-item self-report questionnaire with good reliability and internal consistency (␣ ϭ .78 in this study). The FFMQ is comprised of five mindfulness facets, including nonreactivity to internal experiences (captured by items such as "I watch my feelings without getting lost in them"), observing one's experiences ("I pay attention to sensations, such as the wind in your hair or the sun on my face"), and acting with awareness ("I find myself doing things without paying attention;" Baer et al., 2006) . Items are scored on a 5-point Likert scale (1 ϭ Never or very rarely true, 5 ϭ Very often or always true), and total scores are calculated as summations of subscale items. The FFMQ total score was used in this study.
Opioid craving. Opioid craving was measured with a 10-item prescription opioid adaptation of the Obsessive Compulsive Drug Use Scale-Revised (OCDUS-R; Franken, Hendriks, & van den Brink, 2002; Morgan, Morgenstern, Blanchard, Labouvie, & Bux, 2004 ; ␣ ϭ .91 in this study). This instrument is designed to capture frequency of opioid craving over the past week, assessed by scores on a 5-point Likert scale (0 ϭ no craving, 4 ϭ extreme craving). The authors slightly adjusted wording of items to identify prescription opioid use, changing language such as "How strong is the drive to take drugs?" to "How strong is the drive to take your opioid pain medicine?" Depressed mood. Depressed mood was measured with scores from the Symptoms of Stress Inventory (SOSI; Carlson & Thomas, 2007) Depression subscale (␣ ϭ .89 in this study). The Depression subscale is comprised of eight Likert-type items tapping depressive symptoms on a scale from 1 (never) to 5 (very frequently), including feelings of loneliness and sadness, crying spells, and fatigue. The SOSI has been used as a validated measure of affective symptoms in opioid-treated chronic pain patients (Garland, Brown, & Howard, 2016; Garland, Manusov, et al., 2014) .
Phasic HRV during attention to opioid-related cues. Disposable Ag-AgCl adhesive electrodes were attached to participants' right and left pectoral muscles, and electrocardiogram (ECG) data were continuously sampled at 1,000 Hz on a BIOPAC MP 150 (BIOPAC Systems, Inc., Goleta, CA). Baseline HRV was collected during a 5-min period in which participants were asked to remain silent and motionless, after which they completed the dot-probe task. R-R wave intervals in the ECG waveforms were initially detected automatically in AcqKnowledge 4.1 (BIOPAC), and then visually inspected to correct missed or incorrectly identified R-waves.
Phasic HRV during attention to opioid-related cues was assessed with a computerized dot probe task (E-Prime, PST Inc., Pittsburgh, PA). A fixation cross was presented for 500 ms at the beginning of each trial. Then, pairs of photos containing one opioid-related image (e.g., pills, pill bottles) and one neutral image-matched for visual complexity, composition, and figure-ground relationships-were presented side-by-side on the computer screen for either 200 or 2,000 ms across 64 trials. Opioid cues consisted of 12 images of pills and pill bottles selected from media libraries on the Internet, and neutral cues consisted of 12 neutral images selected from the International Affective Picture System (IAPS; Lang, Bradley, & Cuthbert, 1997) . Presentation duration and left-right position of the images were randomized and counterbalanced. Both images disappeared simultaneously, followed by a 50-ms interstimulus interval, after which a target probe replaced one of the images. Probes appeared for 100 ms, and probe location was counterbalanced. The total epoch of the dot-probe opioid-cue condition was 2 min in length. Participants designated left or right probe location with a left or right button press.
Analysis
Kubios 2.0 (Biosignal Analysis and Medical Imaging Group, Finland University, Helsinki, Finland) was used for Time-domain analysis of R-waves. The root-mean square of successive differences (RMSSD) in R-R= intervals was used to compute HRV (Kleiger, Stein, & Bigger, 2005; Thayer & Lane, 2000) . Although some researchers suggest that RMSSD and other Time-domain measures of HRV are less optimal than Frequency-domain measures such as high-frequency (HF) HRV (Berntson, Quigley, & Lozano, 2007) , we selected RMSSD as our measure of phasic HRV in this study, given that it is considered to be less affected by respiratory influences than spectral HRV measures (Hill & Siebenbrock, 2009 ). Indeed, it has been suggested that RMSSD is preferable to spectral HRV measures in experiments in which respiratory confounds are likely to be present (Penttilä et al., 2001) . In light of well-documented effects of opioids on respiratory depression, activation of opioid receptors does not appear to have an effect on HRV (Ellidokuz et al., 2008) , but respiratory depression is a known side effect of opioids (Boom et al., 2012; Jarzyna et al., 2011) . Thus, we selected RMSSD in an effort to remove the potentially confounding influence of respiration inherent to Frequency-domain measures of HRV. RMSSD values were averaged across the 5-min baseline and the dot-probe opioid-cue condition.
For hypothesis testing, we used the following multistage analytic approach. First, we computed Pearson's correlations to assess This document is copyrighted by the American Psychological Association or one of its allied publishers.
the unadjusted, zero-order relationships between dispositional mindfulness, resting HRV, phasic HRV during opioid-cue exposure, depression, and opioid craving. We also tested a linear regression model in which dispositional mindfulness served as the independent variable, HRV during opioid-cue exposure was the dependent variable, and baseline resting HRV was used as a covariate. Next, we created a residualized HRV score representing phasic HRV during attention to opioid cues (HRV-cue responsivity) by saving the residuals after covarying resting HRV from HRV during opioid-cue exposure. Finally, we conducted a multivariate path analysis with full-information maximum likelihood estimation using SPSS AMOS 24 to examine this phasic HRV variable, and SOSI-Depressed scale (Carlson & Thomas, 2007) mood scores as mediators of the association between dispositional mindfulness and opioid craving. Unstandardized indirect effects were computed for each of 1,000 bootstrapped samples, and the 95% CI was computed by determining the indirect effects at the 2.5th and 97.5th percentiles. Significance of each indirect effect was indicated by the upper and lower limits of the 95% CI not spanning zero (Preacher & Hayes, 2008) . This method has been recommended as superior to a normal theoretical approach to testing mediation (e.g., the Sobel test) because it does not assume normality of the indirect effect sampling distribution. Model fit was determined using fit indices recommended by Kline (1998) , including a 2 /df ratio between 1 and 3 (Carmines & McIver, 1981) , comparative fit index (CFI) Ͼ 0.90, and the root-meansquare error of approximation (RMSEA) Յ 0.08 (Browne & Cudeck, 1992) .
Results

Sample Characteristics
Data were obtained from chronic pain patients (N ϭ 115) who had been prescribed long-term analgesic opioid therapy. Most participants were women (68%, mean age ϭ 48.3 Ϯ 13.6), Caucasian (65%), had completed some college-level education (70%), and a large portion (46%) reported annual incomes less than $40,000. Demographics are depicted in Table 1 .
Bivariate Associations Between Phasic HRV and Clinical Variables
Bivariate correlations confirmed expected directionalities of variable relationships. Mindfulness scores were significantly positively correlated with resting HRV and phasic HRV during opioid-cue-exposure-both with moderate effect sizes, and significantly negatively correlated with both depression and opioid craving-also with moderate effect sizes. Depression and opioid craving were positively correlated with a moderate effect size. In contrast, the small effect-size correlation between HRV and depression was nonsignificant. Pearson's correlations are depicted in Table 2 , and effect-size interpretations are consistent with those outlined by Cohen (1988) .
Linear Regression Analysis
Linear regression indicated that dispositional mindfulness was significantly positively associated with phasic HRV during opioidcue-exposure (B ϭ .58, SE ϭ .23, p ϭ .01, model R 2 ϭ .57), after controlling for baseline resting HRV.
Multivariate Path Analysis
Our multivariate path model (see Figure 1) revealed that phasic HRV and depression were partial mediators of the relationship between dispositional mindfulness and opioid craving during attention to drug-related stimuli ( 2 /df ϭ .53, CFI ϭ 1, RMSEA ϭ .00). The regression coefficient between dispositional mindfulness and phasic HRV was statistically significant (B ϭ .56, SE ϭ .20, p ϭ .005) with a medium effect size (r ϭ .24), as was the regression coefficient between phasic HRV and craving (B ϭ Ϫ.08, SE ϭ .25, p ϭ .006). The regression coefficient between dispositional mindfulness and depression was also statistically significant (B ϭ Ϫ.17, SE ϭ .05, p ϭ .001) with a medium effect size (r ϭ .35), as was that between depression and craving (B ϭ .44, SE ϭ .12, p ϭ .002). With these two mediational pathways entered into the model, the direct effect of dispositional mindfulness on craving became nonsignificant (B ϭ .02, SE ϭ .06, p ϭ .44). The bootstrapped, unstandardized indirect effect of dispositional mindfulness on craving through phasic HRV was Ϫ.03 (SE ϭ .02), 95% Bootstrapped confidence interval (BCI) [-.09, Ϫ.001], and through depression was Ϫ.08 (SE ϭ .03), 95% BCI [-.15, Ϫ.02], indicating that phasic HRV and depression were both statistically significant mediators in the relationship between dispositional mindfulness and opioid craving, together accounting for 21% of the variance in the model.
Discussion
Self-regulation is an essential feature of adaptive behavior and is central to the effective management of drug craving. According to the neurovisceral integration model (Thayer & Lane, 2000 , self-regulation is achieved through attentional and emotional processes, in conjunction with downstream effects on autonomic responses. In the present investigation of a community sample of opioid-treated chronic pain patients, we found that dispositional This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
mindfulness, a construct closely linked with heightened selfregulatory capacity, was positively associated with phasic HRV during opioid-cue exposure, and with lower depressed mood-two potential mechanisms of action that mediated the inverse association between mindfulness and opioid craving.
Mindfulness, HRV, and Craving
Findings revealed that dispositional mindfulness was positively correlated with phasic HRV and phasic HRV was inversely correlated with opioid craving, with phasic HRV mediating the association between dispositional mindfulness and craving. The indirect effect of dispositional mindfulness on craving through phasic HRV suggests that greater autonomic flexibility (Friedman, 2007) could be a key mechanism by which higher dispositional mindfulness buffers against addictive behaviors. This mediational mechanism might be understood through the lens of the dynamical systems model proposed by Thayer and Lane (2000) , who discuss goal-directed behavior (e.g., drug consumption perpetuated by craving) as a product of a central autonomic network (CAN), including brain regions implicated in self-regulation of appetitive responses, such as the medial prefrontal cortex, anterior cingulate cortex, insula, amygdala, and striatum (Benarroch, 1993 (Benarroch, , 1997 . CAN outputs modulate heart rate during regulation of attention and emotion (Thayer & Lane, 2000) , making phasic HRV a possible marker of flexible self-regulation in the face of appetitive cues. Hence, it seems that as phasic HRV increases from baseline levels, so too might the ability to inhibit maladaptive responding. In the context of the present analysis, this process translates to lower drug craving among individuals exhibiting the enhanced autonomic flexibility associated with higher levels of dispositional mindfulness.
In light of literature supporting phasic HRV as an index of self-regulation (Holzman & Bridgett, 2017; Segerstrom & Nes, This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
2007), it seems reasonable to presume that higher phasic HRV observed among opioid-treated patients with high dispositional mindfulness scores may indicate greater capacity to self-regulate in the face of opioid cues. This interpretation is consistent with prior research demonstrating associations between dispositional mindfulness, reduced alcohol-attentional bias, and higher phasic HRV following alcohol-cue exposure among a sample of alcoholdependent individuals (Garland, 2011) . It is plausible that dispositional mindfulness enables parasympathetic control during attention to emotional information, thereby facilitating successful down regulation of sympathetically-driven cue-reactivity, with consequent effects on reducing subjective craving. However, in light of the fact that RMSSD may capture both sympathetic and parasympathetic activity (Berntson, Lozano, & Chen, 2005) , this physiological inference can only be taken as logical conjecture. Future researchers should aim to unpack these nuances to promote deeper understanding of how vagal tone influences craving.
Mindfulness, Depression, and Craving
Findings revealed that dispositional mindfulness was inversely correlated with depression, and depression was positively associated with opioid craving, with depression also mediating the association between dispositional mindfulness and craving. The direct effect of dispositional mindfulness on depression is consistent with behavioral research demonstrating associations between dispositional mindfulness, depression, and psychological well-being (Brown & Ryan, 2003; Hanley & Garland, 2017; Jimenez, Niles, & Park, 2010) . This direct effect is also consistent with neurobiological evidence that dispositional mindfulness is associated with reduced amygdala reactivity to negative emotional stimuli (Way, Creswell, Eisenberger, & Lieberman, 2010) and with smaller amygdala volumes (Taren, Creswell, & Gianaros, 2013) .
The observed association between depression and opioid craving may be understood as a function of conditioned negative reinforcement. That is, opioid cues could be associated with reprieve from the emotional suffering that accompanies chronic pain, thereby eliciting a conditioned response (i.e., craving) to promote opioid consumption as a means of achieving desired emotional relief (Childress, McLellan, Ehrman, & O'Brien, 1988; Martel et al., 2014) . A recent neuroimaging study of self-control deficits in the face of negative affect provides an alternative lens through which to understand the direct effect of depression on craving. Researchers found that, contrary to the widely accepted notion that self-regulatory deficits occur as a simple failure to recruit resources from the prefrontal cortex, these deficits actually appear to be a function of excessive self-regulatory taxation when disinhibition occurs in conjunction with negative emotion (Chester et al., 2016) . From this perspective, it is possible that overregulation of negative emotion may exhaust self-regulatory resources, thereby limiting an individual's capacity to manage craving.
The source of the direct effect of depression on craving may hold considerable implications for how to interpret the indirect effect of dispositional mindfulness on craving through depression. Insofar as individuals high in dispositional mindfulness may be subject to less negative affectivity (Brown & Ryan, 2003; Paulus, Langdon, Wetter, & Zvolensky, 2018) , lower depressed mood among mindful individuals may explain their comparatively lower levels of craving driven by a desire to ameliorate negative emotions. Alternatively, it could be that the heightened executive control associated with mindfulness (Teper et al., 2013 ) is made possible, in part, by greater self-regulatory resource availability associated with lower negative emotion (Chester et al., 2016) , or vice versa. In this case, the indirect effect might be understood not as a function of reduced depression, but rather of the attenuation of depression's impact on the capacity for self-regulation. Future research may benefit from inclusion of additional measures, such as probes of emotion regulation and executive functioning, to more clearly partition the relationships elucidated by the present study.
Conclusion
Extensive research has focused on illuminating the functional links specified by the neurovisceral integration model between central and autonomic nervous system structures implicated in attentional control and emotional experience (Nyklíček, Thayer, & van Doormen, 1997; Thayer & Lane, 2000 , and together these biobehavioral processes appear to subserve self-regulation and adaptive responding. The results of the present study provide support for the neurovisceral model in the context of addiction, capturing two pathways by which dispositional mindfulness attenuates craving: one through autonomic regulation of drug-cue reactivity, the other through lower levels of negative affect.
Although these findings hold preliminary implications for the role of mindfulness in prevention of and recovery from opioid misuse, there are several limitations to this study. First, causal inferences regarding directionality in the proposed mediational pathways are precluded by the cross-sectional design of this study. As Baron and Kenny (1986) outlined, changes in the mediator must precede changes in the dependent variable to establish causality. Future studies employing longitudinal designs could yield causal inferences by providing more insight into the directionality of associations evinced in this study. Similarly, without a control group, we could not provide a comparator to contextualize the sample with regard to the broader literature. Although data from the present study were limited to individual difference analyses, this analytic approach has long been recognized as a valid means of assessing psychobiological mediators of the relation between dispositional factors and physiological responses to environmental challenges (Kosslyn et al., 2002) . Nonetheless, future iterations of this research would benefit from inclusion, not only of healthy controls, but also of chronic pain patients not on prescription opioids, to provide further clarity. Self-report measures are also potentially problematic features of the study's design, as social desirability bias may have influenced the extent to which constructs of interest were accurately captured. Finally, the unique clinical features of the sample may limit the generalizability of study results to chronic pain patients treated with extended opioid pharmacotherapy and might not be applicable to other forms of substance use and misuse.
In conclusion, higher levels of dispositional mindfulness were associated with lower opioid craving among this sample of chronic pain patients taking prescription opioid analgesics, and phasic HRV during attention to opioid cues and depression significantly mediated this relationship. These preliminary findings suggest that dispositional mindfulness may be a valuable buffer against physiological and emotional risk factors implicated in drug craving. As such, psychological interventions designed to cultivate mindfulThis document is copyrighted by the American Psychological Association or one of its allied publishers.
ness (e.g., Mindfulness-Oriented Recovery Enhancement, see Garland, Manusov, et al., 2014) may be an effective, nonpharmacological means of ameliorating opioid craving and cue-reactivity and help to stem the rising public health crisis of opioid misuse.
